$CYAN
CYANOTECH CORP

2018 Q4 Form 10-Q Financial Statement

#000143774919002456 Filed on February 13, 2019

View on sec.gov

Income Statement

Concept 2018 Q4 2017 Q4
Revenue $10.04M $9.150M
YoY Change 9.77% 20.32%
Cost Of Revenue $5.928M $4.910M
YoY Change 20.73% 3.41%
Gross Profit $4.116M $4.240M
YoY Change -2.92% 48.41%
Gross Profit Margin 40.98% 46.34%
Selling, General & Admin $3.405M $2.988M
YoY Change 13.96% 3.5%
% of Gross Profit 82.73% 70.47%
Research & Development $216.0K $142.0K
YoY Change 52.11% -0.7%
% of Gross Profit 5.25% 3.35%
Depreciation & Amortization $471.0K $460.0K
YoY Change 2.39% -4.17%
% of Gross Profit 11.44% 10.85%
Operating Expenses $3.621M $3.130M
YoY Change 15.69% 3.3%
Operating Profit $495.0K $1.110M
YoY Change -55.41% -741.62%
Interest Expense $134.0K -$130.0K
YoY Change -203.08% -12.75%
% of Operating Profit 27.07% -11.71%
Other Income/Expense, Net
YoY Change
Pretax Income $361.0K $980.0K
YoY Change -63.16% -404.35%
Income Tax $73.00K -$127.0K
% Of Pretax Income 20.22% -12.96%
Net Earnings $288.0K $1.107M
YoY Change -73.98% -417.19%
Net Earnings / Revenue 2.87% 12.1%
Basic Earnings Per Share $0.05 $0.19
Diluted Earnings Per Share $0.05 $0.19
COMMON SHARES
Basic Shares Outstanding 5.836M 5.749M
Diluted Shares Outstanding 5.862M 5.831M

Balance Sheet

Concept 2018 Q4 2017 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.570M $1.760M
YoY Change -10.8% 6.02%
Cash & Equivalents $1.573M $1.763M
Short-Term Investments
Other Short-Term Assets $640.0K $550.0K
YoY Change 16.36% -33.73%
Inventory $10.11M $9.702M
Prepaid Expenses
Receivables $1.883M $2.926M
Other Receivables $0.00 $0.00
Total Short-Term Assets $14.21M $14.94M
YoY Change -4.92% 18.3%
LONG-TERM ASSETS
Property, Plant & Equipment $15.18M $15.95M
YoY Change -4.78% -5.47%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $291.0K $317.0K
YoY Change -8.2% 42.79%
Total Long-Term Assets $15.47M $16.33M
YoY Change -5.22% -4.46%
TOTAL ASSETS
Total Short-Term Assets $14.21M $14.94M
Total Long-Term Assets $15.47M $16.33M
Total Assets $29.68M $31.27M
YoY Change -5.08% 5.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.055M $3.590M
YoY Change 12.95% 1.18%
Accrued Expenses $1.073M $1.345M
YoY Change -20.22% -3.65%
Deferred Revenue $172.0K
YoY Change
Short-Term Debt $2.080M $500.0K
YoY Change 316.0% -18.03%
Long-Term Debt Due $660.0K $660.0K
YoY Change 0.0% 8.2%
Total Short-Term Liabilities $8.045M $6.130M
YoY Change 31.24% -1.84%
LONG-TERM LIABILITIES
Long-Term Debt $5.330M $5.950M
YoY Change -10.42% -7.03%
Other Long-Term Liabilities $60.00K $110.0K
YoY Change -45.45% 175.0%
Total Long-Term Liabilities $5.390M $6.060M
YoY Change -11.06% -5.9%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.045M $6.130M
Total Long-Term Liabilities $5.390M $6.060M
Total Liabilities $13.43M $12.19M
YoY Change 10.21% -4.51%
SHAREHOLDERS EQUITY
Retained Earnings -$16.18M -$13.00M
YoY Change 24.47% -12.22%
Common Stock $117.0K $115.0K
YoY Change 1.74% 1.77%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $16.25M $19.09M
YoY Change
Total Liabilities & Shareholders Equity $29.68M $31.27M
YoY Change -5.08% 5.22%

Cashflow Statement

Concept 2018 Q4 2017 Q4
OPERATING ACTIVITIES
Net Income $288.0K $1.107M
YoY Change -73.98% -417.19%
Depreciation, Depletion And Amortization $471.0K $460.0K
YoY Change 2.39% -4.17%
Cash From Operating Activities $1.270M $80.00K
YoY Change 1487.5% -500.0%
INVESTING ACTIVITIES
Capital Expenditures -$140.0K -$390.0K
YoY Change -64.1% 69.57%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$70.00K
YoY Change -100.0%
Cash From Investing Activities -$140.0K -$450.0K
YoY Change -68.89% 95.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -220.0K 40.00K
YoY Change -650.0% -128.57%
NET CHANGE
Cash From Operating Activities 1.270M 80.00K
Cash From Investing Activities -140.0K -450.0K
Cash From Financing Activities -220.0K 40.00K
Net Change In Cash 910.0K -330.0K
YoY Change -375.76% -15.38%
FREE CASH FLOW
Cash From Operating Activities $1.270M $80.00K
Capital Expenditures -$140.0K -$390.0K
Free Cash Flow $1.410M $470.0K
YoY Change 200.0% 123.81%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q4 cyan Inventory Abnormal Production Costs
InventoryAbnormalProductionCosts
0
cyan Inventory Abnormal Production Costs
InventoryAbnormalProductionCosts
250000
CY2017Q4 cyan Inventory Abnormal Production Costs
InventoryAbnormalProductionCosts
0
cyan Inventory Abnormal Production Costs
InventoryAbnormalProductionCosts
0
CY2018Q4 cyan Longterm Debt And Capital Lease Obligations Net Of Issuance Costs
LongtermDebtAndCapitalLeaseObligationsNetOfIssuanceCosts
5328000
CY2018Q1 cyan Longterm Debt And Capital Lease Obligations Net Of Issuance Costs
LongtermDebtAndCapitalLeaseObligationsNetOfIssuanceCosts
5790000
cyan Non Inventoriable Fixed Costs
NonInventoriableFixedCosts
176000
CY2018Q4 cyan Number Of Shareholder Approved Sharebased Compensation Plans
NumberOfShareholderApprovedSharebasedCompensationPlans
2
cyan Repayments Of Short Term Contractual Obligation
RepaymentsOfShortTermContractualObligation
63000
cyan Repayments Of Short Term Contractual Obligation
RepaymentsOfShortTermContractualObligation
CY2018Q4 us-gaap Assets Current
AssetsCurrent
14209000
CY2018Q1 us-gaap Assets Current
AssetsCurrent
13617000
CY2018Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
27000
CY2018Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
3527000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1883000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
57000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4055000
CY2018Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2664000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1073000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
52000
CY2018Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
892000
CY2018Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
799000
CY2018Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
707000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
18767000
CY2018Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
17346000
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
32318000
CY2018Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
32051000
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
27000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2018 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2018Q4 us-gaap Assets
Assets
29683000
CY2018Q1 us-gaap Assets
Assets
29707000
CY2018Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1573000
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1329000
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1407000
CY2018Q4 us-gaap Capital Lease Obligations
CapitalLeaseObligations
98000
CY2018Q1 us-gaap Capital Lease Obligations
CapitalLeaseObligations
148000
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1394000
CY2017Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1407000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1573000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1763000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
179000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
356000
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.02
CY2018Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.02
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000000
CY2018Q1 us-gaap Common Stock Value
CommonStockValue
115000
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; font-weight: bold;">Concentration of Accounts Receivable and Revenues</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:15pt;margin-right:7.5pt;margin-top:0pt;text-align:left;text-indent:28.5pt;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-indent: 45pt;">At <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2018, </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">67%</div> of the Company&#x2019;s accounts receivable was comprised of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> customer balances of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">43%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">24%,</div> respectively. At <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 31, 2018, </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">76%</div> of the Company&#x2019;s accounts receivable was comprised of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> customer balances of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">45%,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15%,</div> respectively. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Two </div>customers accounted for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">66%</div> of total net sales for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2018, </div>comprised of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">35%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31%,</div> respectively. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Two </div>customers accounted for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">50%</div> of total net sales for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017, </div>comprised of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">26%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">24%,</div> respectively. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Two </div>customers accounted for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">62%</div> of total net sales for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2018, </div>comprised of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">35%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">27%,</div> respectively. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Two </div>customers accounted for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">47%</div> of total net sales for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017, </div>comprised of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17%,</div> respectively.</div></div></div></div></div></div></div></div></div></div>
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5836110000
CY2018Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5772032000
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5836110000
CY2018Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5772032000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
117000
CY2018Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
1002000
CY2018Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
549000
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
172000
CY2018Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
133000
CY2018Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5928000
CY2017Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4910000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
15906000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
14551000
CY2018Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
208000
CY2018Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
233000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1421000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1403000
CY2018Q4 us-gaap Dilutive Securities
DilutiveSecurities
CY2017Q4 us-gaap Dilutive Securities
DilutiveSecurities
us-gaap Dilutive Securities
DilutiveSecurities
CY2018Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2017Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.37
CY2017Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.13
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.053
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2018Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1337000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4190000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.36
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.37
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.36
CY2018Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2017Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.37
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.36
CY2018Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.202
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.016
CY2017Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1368000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4132000
CY2018Q4 us-gaap Gross Profit
GrossProfit
4116000
CY2017Q4 us-gaap Gross Profit
GrossProfit
4240000
us-gaap Gross Profit
GrossProfit
8237000
us-gaap Gross Profit
GrossProfit
11463000
CY2018Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
361000
CY2017Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
980000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2090000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1978000
CY2018Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
73000
CY2017Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-127000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
33000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-105000
CY2018Q4 us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
73000
CY2017Q4 us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
127000
us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
33000
us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
105000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
17000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
528000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-76000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-781000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
791000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
181000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
332000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
39000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-80000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1078000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1730000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-46000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-8000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
84000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
86000
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
65000
CY2018Q4 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-134000
CY2017Q4 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-130000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-414000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-371000
us-gaap Interest Paid Net
InterestPaidNet
358000
us-gaap Interest Paid Net
InterestPaidNet
313000
CY2018Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
4828000
CY2018Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
5878000
CY2018Q4 us-gaap Inventory Net
InventoryNet
10112000
CY2018Q1 us-gaap Inventory Net
InventoryNet
9034000
CY2018Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
460000
CY2018Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
410000
CY2018Q4 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
175000
CY2018Q1 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
144000
CY2018Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4649000
CY2018Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2602000
CY2018Q4 us-gaap Liabilities
Liabilities
13430000
CY2018Q1 us-gaap Liabilities
Liabilities
11600000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
29683000
CY2018Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
29707000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8045000
CY2018Q1 us-gaap Liabilities Current
LiabilitiesCurrent
5707000
CY2018Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
1750000
CY2018Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
500000
CY2018Q4 us-gaap Long Term Debt
LongTermDebt
6101000
CY2018Q1 us-gaap Long Term Debt
LongTermDebt
6530000
CY2018Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
5536000
CY2018Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
6023000
CY2018Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
663000
CY2018Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
655000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
696000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-380000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-475000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-732000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-42000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1468000
us-gaap Net Income Loss
NetIncomeLoss
-2123000
us-gaap Net Income Loss
NetIncomeLoss
2083000
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
288000
CY2017Q4 us-gaap Net Income Loss
NetIncomeLoss
1107000
CY2018Q4 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
288000
CY2017Q4 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
1107000
CY2018Q4 us-gaap Operating Expenses
OperatingExpenses
3621000
CY2017Q4 us-gaap Operating Expenses
OperatingExpenses
3130000
us-gaap Operating Expenses
OperatingExpenses
9913000
us-gaap Operating Expenses
OperatingExpenses
9114000
CY2018Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
495000
CY2017Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
1110000
us-gaap Operating Income Loss
OperatingIncomeLoss
-1676000
us-gaap Operating Income Loss
OperatingIncomeLoss
2349000
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
274000
CY2018Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
185000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
291000
CY2018Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
291000
CY2018Q4 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
57000
CY2018Q1 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
103000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
32000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
us-gaap Payments To Acquire Buildings
PaymentsToAcquireBuildings
100000
us-gaap Payments To Acquire Buildings
PaymentsToAcquireBuildings
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
375000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
667000
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000000
CY2018Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000000
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
641000
CY2018Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
590000
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; font-weight: bold;">Reclassification</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.5pt;text-align:left;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-indent: 45pt;">Certain amounts previously reported in the fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> consolidated financial statements have been reclassified to conform with the fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> financial presentation. These reclassifications have <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> impact on net income.</div></div></div></div></div></div></div></div></div></div>
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
166000
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
1250000
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-111000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
19000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
26000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
32948000
CY2018Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
32531000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15183000
CY2018Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15734000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
49000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
67000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
429000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
394000
CY2018Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
216000
CY2017Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
142000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
635000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
433000
CY2018Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
65000
CY2017Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
CY2018Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
CY2018Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
CY2018Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
65000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-16182000
CY2018Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-14059000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
1650000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1297422
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
483400
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.15
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
5000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
CY2018Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2068000
CY2017Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1620000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5088000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
675300
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
43804
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
589400
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
578400
CY2018Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10044000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
24143000
CY2017Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9150000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
26014000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4549000
us-gaap Share Based Compensation
ShareBasedCompensation
282000
us-gaap Share Based Compensation
ShareBasedCompensation
369000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
629375
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.06
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.06
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.85
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
5.75
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2018Q4 us-gaap Share Price
SharePrice
3.02
CY2018Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
43804
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y109D
CY2018Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
120000
CY2018Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
95000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
CY2018Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.81
CY2018Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.83
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y328D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y73D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
25000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
1.71
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
16253000
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
18107000
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2018Q4 us-gaap Short Term Non Bank Loans And Notes Payable
ShortTermNonBankLoansAndNotesPayable
332000
CY2018Q1 us-gaap Short Term Non Bank Loans And Notes Payable
ShortTermNonBankLoansAndNotesPayable
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
6000
us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; font-weight: bold;">Use of Estimates</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.5pt;text-align:left;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-indent: 45pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosures of any contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the periods reported.&nbsp; Management reviews these estimates and assumptions periodically and reflects the effect of revisions in the period that they are determined to be necessary.&nbsp; Actual results could differ from those estimates and assumptions.</div></div></div></div></div></div></div></div></div></div>
CY2018Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
26000
CY2017Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
82000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
60000
CY2018Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5862000
CY2017Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5831000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5809000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5774000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5809000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5774000
CY2018Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5836000
CY2017Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5749000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5809000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5714000

Files In Submission

Name View Source Status
0001437749-19-002456-index-headers.html Edgar Link pending
0001437749-19-002456-index.html Edgar Link pending
0001437749-19-002456.txt Edgar Link pending
0001437749-19-002456-xbrl.zip Edgar Link pending
a1.jpg Edgar Link pending
cyan-20181231.xml Edgar Link completed
cyan-20181231.xsd Edgar Link pending
cyan-20181231_cal.xml Edgar Link unprocessable
cyan-20181231_def.xml Edgar Link unprocessable
cyan-20181231_lab.xml Edgar Link unprocessable
cyan-20181231_pre.xml Edgar Link unprocessable
cyan20181231_10q.htm Edgar Link pending
ex_134032.htm Edgar Link pending
ex_134033.htm Edgar Link pending
ex_134034.htm Edgar Link pending
ex_134617.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending